Roll-call vote · 20 January 2026

Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest ***I

Amendments by the committee responsible – separate vote

Part of: 2025/0102(COD) · first reading
Adopted
For 494Against 152Abstain 17

This is the vote on Amendment 162. We record the outcome and the full roll-call below — but not the amendment’s wording: what it proposed to change isn’t in our data yet (it lives in the tabled-amendment documents, which we don’t ingest).

How the vote split

for · against · abstain

By political group

PPE157·23·0
S-D122·0·2
PFE0·79·0
ECR59·13·0
RENEW54·8·6
VERTS-ALE51·0·0
THE-LEFT38·1·0
NI13·4·9
ESN0·24·0

By country

Germany66·13·10
Italy66·7·0
France33·39·0
Spain47·6·0
Poland44·5·0
Netherlands18·12·0
Romania30·0·0
Greece15·3·3
Czechia9·11·0

Every vote cast

663 recorded positions
Download CSVShowing 1–10 of 663
Abir AL-SAHLANIRENEW · SWEFor
Adam BIELANECR · POLFor
Adam JARUBASPPE · POLFor
Adina VĂLEANPPE · ROUFor
Adnan DIBRANIS-D · SWEFor
Afroditi LATINOPOULOUPFE · GRCAgainst
Alberico GAMBINOECR · ITAFor
Aleksandar NIKOLICPFE · FRAAgainst
Alessandra MORETTIS-D · ITAFor